FDA Approves Durvalumab for Muscle Invasive Bladder Cancer By Ogkologos - May 2, 2025 668 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the NIAGARA study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR “Things Are Shrinking” Says Olivia Newton-John About Her Stage IV Breast... February 18, 2020 The ecDNA story – catching the mastermind behind cancer evolution February 20, 2023 FDA Grants Accelerated Approval to Naxitamab for High-Risk Neuroblastoma in Bone... November 27, 2020 Great Oaks Grow From Small Acorns Oncology Is Committed to Doing... September 9, 2022 Load more HOT NEWS Bowel Cancer Data Reinforce Need to Reduce Unnecessary Antibiotic Use [ESMO... Breaking: Longtime Broadcast Journalist Cokie Roberts Dies At 75 ΚΑΡΚΙΝΟΣ ΘΥΡΕΟΕΙΔΟΥΣ Foodie Friday: What to do with all these zucchini?
